WO2024200489 - BLOOD BIOMARKERS FOR MONITORING CHANGES IN THE AMOUNT OF VISCERAL ADIPOSE TISSUE
National phase entry:
Publication Number
WO/2024/200489
Publication Date
03.10.2024
International Application No.
PCT/EP2024/058201
International Filing Date
27.03.2024
Title **
[English]
BLOOD BIOMARKERS FOR MONITORING CHANGES IN THE AMOUNT OF VISCERAL ADIPOSE TISSUE
[French]
BIOMARQUEURS SANGUINS POUR SURVEILLER DES CHANGEMENTS DE LA QUANTITÉ DE TISSU ADIPEUX VISCÉRAL
Applicants **
RANDOX LABORATORIES LTD
55 Diamond Road
Ardmore
Crumlin Antrim BT294QY, GB
Inventors
INNOCENZI, Paul
Randox Laboratories
Ardmore
55 Diamond Road
Crumlin Antrim BT294QY, GB
FITZGERALD, Peter
Randox Laboratories
Ardmore
55 Diamond Road
Crumlin Antrim BT294QY, GB
MCCONNELL, Ivan
Ardmore
55 Diamond Road
Crumlin Antrim BT29 4QY, GB
Priority Data
2304612.1
29.03.2023
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1021 | |
| EPO | Filing, Examination | 4644 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2635 |
Total: 9406 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Methods are described for the biomarker-based identification of a change in the amount of visceral adipose tissue (VAT) in individuals with a healthy BMI and a healthy waist circumference. The early identification of VAT changes using commonly measured clinical biomarkers when incorporated with exercise and nutritional advice enables the expeditious implementation of the END approach (Exercise Nutrition & Diagnostics) to manage the burgeoning overweight and obesity pandemic.[French]
L'invention concerne des procédés pour l'identification basée sur un biomarqueur d'un changement de la quantité de tissu adipeux viscéral (VAT) chez des individus présentant un IMC sain et une circonférence de taille saine. L'identification précoce de changements de VAT à l'aide de biomarqueurs cliniques couramment mesurés lorsqu'elle est incorporée à des conseils d'exercice et de nutrition permet la mise en œuvre accélérée de l'approche END (exercice, nutrition et diagnostic) pour gérer la pandémie de surpoids et d'obésité en plein essor.